Connection

Gavin Screaton to Dengue Virus

This is a "connection" page, showing publications Gavin Screaton has written about Dengue Virus.
Connection Strength

1.511
  1. Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response. Nat Immunol. 2017 Nov; 18(11):1228-1237.
    View in: PubMed
    Score: 0.404
  2. The immunopathology of dengue and Zika virus infections. Curr Opin Immunol. 2017 10; 48:1-6.
    View in: PubMed
    Score: 0.399
  3. Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat Commun. 2017 05 23; 8:15411.
    View in: PubMed
    Score: 0.395
  4. Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine. J Virol. 2018 12 01; 92(23).
    View in: PubMed
    Score: 0.109
  5. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Challenges of a Dengue Vaccine. Cold Spring Harb Perspect Biol. 2018 06 01; 10(6).
    View in: PubMed
    Score: 0.106
  6. Recent advances in human flavivirus vaccines. Curr Opin Virol. 2017 04; 23:95-101.
    View in: PubMed
    Score: 0.098
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.